PMDA — authorised 21 September 2018
- Marketing authorisation holder: Shire Japan KK
- Status: approved
🇯🇵 Firazyr in Japan
PMDA authorised Firazyr on 21 September 2018
Marketing authorisation
Firazyr in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in Japan
Frequently asked questions
Is Firazyr approved in Japan?
Yes. PMDA authorised it on 21 September 2018.
Who is the marketing authorisation holder for Firazyr in Japan?
Shire Japan KK holds the Japanese marketing authorisation.